Similarly in a PTEN-null mouse model, genetic depletion of Smad4 resulted in emergence of more invasive and metastatic prostate cancer when compared to tumors from normal PTEN-null animals that possessed enhanced TGFβ/BMP-Smad4 pathway activation [180]. Here, PTEN is linked to prostate cancer.